The emerging therapy of the medication represents a exciting advance in the care of type 2 diabetes. Distinct from existing drugs, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatide-peptide343988.elbloglibre.com/42430127/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment